Patient Leaflet Updated 02-Nov-2023 | Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Esomeprazole 40 mg powder for solution for injection/infusion.
Esomeprazole 40 mg powder for solution for injection/infusion
esomeprazole
1. What Esomeprazole is and what it is used for
2. What you need to know before Esomeprazole is given to you
3. How Esomeprazole is given to you
4. Possible side effects
5. How to store Esomeprazole
6. Contents of the pack and other information
Esomeprazole contains a medicine called esomeprazole. This belongs to a group of medicines called ‘proton pump inhibitors’. They work by reducing the amount of acid that your stomach produces.
Esomeprazole is used for the short-term treatment of certain conditions, when you are unable to have treatment by mouth. It is used to treat the following conditions:
Adults
Children and adolescents aged 1-18 years
You must not be given Esomeprazole if any of the above apply to you. If you are not sure, talk to your doctor or nurse before you are given this medicine.
Talk to your doctor, or nurse before you are given Esomeprazole if:
Esomeprazole may hide the symptoms of other diseases. Therefore, if any of the following happen to you before you are given Esomeprazole or after you are given it, talk to your doctor straight away:
Taking a proton pump inhibitor like Esomeprazole, especially over a period of more than one year, may slightly increase your risk of fracture in the hip, wrist or spine. Tell your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).
If you get a rash on your skin, especially in areas exposed to the sun tell your doctor as soon as you can, as you may need to stop your treatment with Esomeprazole. Remember to also mention any other ill-effects like pain in your joints.
Serious skin rashes have occurred in patients taking esomeprazole (see also section 4). The rash can involve ulcers of the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes). These serious skin rashes often come after flu-like symptoms such as fever, headache, body ache. The rash may cover large parts of the body with blistering and peeling of the skin.
If at any time during the treatment (even after several weeks) you develop a rash or any of these skin symptoms, stop taking this medicine and contact your doctor immediately.
Tell your doctor or nurse if you are taking, have recently taken, or might take any other medicines. This includes medicines that you buy without a prescription. This is because Esomeprazole can affect the way some medicines work and some medicines can have an effect on Esomeprazole.
You must not be given Esomeprazole if you are taking a medicine containing nelfinavir (used to treat HIV infection).
Tell your doctor or nurse if you are taking any of the following medicines:
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before you are given this medicine. Your doctor will decide whether you can be given Esomeprazole during this time.
It is not known if Esomeprazole passes into breast milk. Therefore, you should not be given Esomeprazole if you are breast-feeding.
Esomeprazole is not likely to affect you being able to drive or use any tools or machines. However, side effects such as dizziness and blurred vision may uncommonly occur (see section 4). If affected, you should not drive or use machines.
This medical product contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially “sodium-free”.
Esomeprazole can be given to children and adolescents aged 1-18 years and adults, including the elderly.
Use in Adults
If you think you have been given too much Esomeprazole, talk to your doctor straight away.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Other side effects include:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Not known (frequency cannot be estimated from the available data)
Esomeprazole SUN may in very rare cases affect the white blood cells leading to immune deficiency. If you have an infection with symptoms such as fever with a severely reduced general condition or fever with symptoms of a local infection such as pain in the neck, throat or mouth or difficulties in urinating, you must consult your doctor as soon as possible so that a lack of white blood cells (agranulocytosis) can be ruled out by a blood test. It is important for you to give information about your medication at this time.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton or vial after EXP. The expiry date refers to the last day of that month.
Store below 30°C. Store in the original package in order to protect from light.
Chemical and physical in-use stability data has been demonstrated for 12 hours at 30°C. From microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2-8°C, unless reconstitution has taken place in controlled and aseptic conditions.
Do not use this medicine if you notice that the visual appearance has changed (only clear solution should be used).
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
Esomeprazole is a white to off-white powder. It comes in a 5 ml colorless glass vial with grey rubber stopper and grey flip off aluminum seal containing 40 mg powder for solution for injection/infusion.
Esomeprazole is available in the following pack sizes:
Not all pack sizes may be marketed.
This medicinal product is authorised in the Member States of the European Economic Area and in the United Kingdom( Northern Ireland) under the following names:
Denmark: Esomeprazol SUN 40 mg pulver til injektions- og infusionsvæske, opløsning
Germany: Esomeprazol SUN 40 mg Pulver zur Herstellung einer Injektions-/Infusionslösung
France: Esomeprazole SUN 40 mg poudre pour solution injectable ou pour perfusion
Italy: Esomeprazolo SUN 40 mg polvere per soluzione iniettabile/infusione
The Netherlands: Esomeprazol SUN 40 mg poeder voor oplossing voor injectie en intraveneuze infusie
Sweden: Esomeprazol SUN 40 mg pulver till injektions-/infusionsvätska, lösning
United Kingdom: (Northern Ireland) Esomeprazole 40 mg powder for solution for injection/infusion.
Poland: Esomeprazol SUN 40 mg proszek do sporządzania roztworu do wstrzykiwań i infuzji
Romania: Esomeprazol SUN 40 mg pulbere pentru soluţie injectabilă/perfuzabilă
This leaflet was last revised in July 2023.
V013
6-9 The Square, Stockley Park, Uxbridge, UB11 1FW, UK
+44 (0) 208 848 5052